Evidence map›Paper›PMID 11292758›Full record

ArticleInfection and immunity2001

Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon.

K P Francis, J Yu, C Bellinger-Kawahara, D Joh, M J Hawkinson, G Xiao, T F Purchio, M G Caparon, M Lipsitch, P R Contag

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 252 citations in OpenAlex.

  1. Article
  2. Factor XII-driven coagulation traps bacterial infections.The Journal of experimental medicine · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. An Autobioluminescent Method for EvaluatingMicrobiology spectrum · 2022
    Article
  9. Constructing ofInternational journal of molecular sciences · 2021
    Article
  10. Article
  11. Chemically SynthesizedMicroorganisms · 2020
    Article
  12. Experimental EvolutionmSystems · 2020
    Article
  13. Article
  14. Article
  15. Genetics of Group A Streptococci.Microbiology spectrum · 2019
    Review
  16. Article
  17. Frontiers in cellular and infection microbiology · 2019
    Article
  18. Article
  19. Article
  20. A Multimodal Imaging Approach EnablesAntimicrobial agents and chemotherapy · 2018
    Article

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

K P FrancisXenogen Corporation, Alameda, California 94501, USA. kfrancis@xenogen.com
J Yu
C Bellinger-Kawahara
D Joh
M J Hawkinson
G Xiao
T F Purchio
M G Caparon
M Lipsitch
P R Contag
Harvard University · USWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Animal studies with Streptococcus pneumoniae have provided valuable models for drug development. In order to monitor long-term pneumococcal infections noninvasively in living mice, a novel gram-positive lux transposon cassette, Tn4001 luxABCDE Km(r), that allows random integration of lux genes onto the bacterial chromosome was constructed. The cassette was designed so that the luxABCDE and kanamycin resistance genes were linked to form a single promoterless operon. Bioluminescence and kanamycin resistance only occur in a bacterial cell if this operon has transposed downstream of a promoter on the bacterium's chromosome. S. pneumoniae D39 was transformed with plasmid pAUL-A Tn4001 luxABCDE Km(r), and a number of highly bioluminescent colonies were recovered. Genomic DNA from the brightest D39 strain was used to transform a number of clinical S. pneumoniae isolates, and several of these strains were tested in animal models, including a pneumococcal lung infection model. Strong bioluminescent signals were seen in the lungs of the animals containing these pneumococci, allowing the course and antibiotic treatment of the infections to be readily monitored in real time in the living animals. Recovery of the bacteria from the animals showed that the bioluminescent signal corresponded to the number of CFU and that the lux construct was highly stable even after several days in vivo. We believe that this lux transposon will greatly expand the ability to evaluate drug efficacy against gram-positive bacteria in living animals using bioluminescence.

Indexed as

DNA Transposable ElementsLuminescent MeasurementsTransformation, BacterialAmoxicillinAnimalsFemaleLungMiceMice, Inbred BALB CNasopharynxOperonPromoter Regions, GeneticStreptococcus pneumoniaeAmoxicillinDNA Transposable Elements

Identifiers

PMID11292758
PMCPMC98294
OpenAlexW1998026338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.